Aiqin Jiang
Jiangsu Key Laboratory Of Molecular Medicine
Nanjing, 210093, China
Nanjing, 210093, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Discovery and antibacterial mechanism of a novel antibacterial agent based on target screening and membrane permeability optimization.
Journal: European journal of medicinal chemistry
Published: April 27, 2026
Novel β-carboline derivatives show promise as dual-target inhibitors of DNA and TOP2A for the treatment of triple negative breast cancer.
Journal: European journal of medicinal chemistry
Published: April 02, 2025
Caerulomycin A disrupts glucose metabolism and triggers ER stress-induced apoptosis in triple-negative breast cancer cells.
Journal: Chinese journal of natural medicines
Published: December 03, 2024
Recent Progress in Small Molecular Inhibitors of DNA Gyrase.
Journal: Current medicinal chemistry
Published: September 14, 2020
Detection Methods and Research Progress of Human Serum Albumin.
Journal: Critical reviews in analytical chemistry
Published: July 30, 2020
Effect of salt concentration on microbial communities, physicochemical properties and metabolite profile during spontaneous fermentation of Chinese northeast sauerkraut.
Journal: Journal of applied microbiology
Published: May 30, 2020
A patent review of RAF kinase inhibitors (2010-2018).
Journal: Expert opinion on therapeutic patents
Published: August 03, 2019
A class of novel tubulin polymerization inhibitors exert effective anti-tumor activity via mitotic catastrophe.
Journal: European journal of medicinal chemistry
Published: November 13, 2018
FAK inhibitors in Cancer, a patent review.
Journal: Expert opinion on therapeutic patents
Published: December 07, 2017
Carrier Cells for Delivery of Oncolytic Measles Virus into Tumors: Determinants of Efficient Loading.
Journal: Virologica Sinica
Published: November 16, 2017
Last Updated: 09/26/2026